Dr. Maria Rae Evasovich, MD

Dr. Evasovich practices at M Health Fairview University of Minnesota Medical Center in Minneapolis, Minnesota, part of M Health Fairview.

Dr. Evasovich's NPI, 1326077611, was assigned on July 1, 2006. Dr. Evasovich graduated from Medical College of Georgia School of Medicine in 1992. Dr. Evasovich holds Minnesota license 44538.

Dr. Evasovich's primary practice is M Health Fairview University of Minnesota Medical Center, at 2450 Riverside Avenue, Minneapolis, MN 55454 in Hennepin County. The practice phone is (612) 624-1765.

Dr. Evasovich's primary practice is M Health Fairview University of Minnesota Medical Center in Minneapolis, Minnesota, part of M Health Fairview. Dr. Evasovich is also affiliated with M Health Fairview Southdale Hospital. The medical group on file is M Health Fairview Recovery Clinic. Dmand AI also links Dr. Evasovich to 5 more group practices and clinics, 5 medical groups and 1 dialysis center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Evasovich practices, 8 sites in all. Vendor and product names are available with a free account.

Surgical oncology is Dr. Evasovich's primary specialty in the NPI Registry, under taxonomy code 2086X0206X. Dr. Evasovich is licensed in Minnesota.

CMS data shows 52 Medicare services from Dr. Evasovich across 3 procedure codes in 2024, for 57 Medicare patients. Medicare paid $12,541 for them.

CMS counts 57 Medicare patients who saw Dr. Evasovich in 2024. The largest group is 65 to 74, with 31 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 28% are also on Medicaid. Their average risk score is 2.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Evasovich's median patient age at 61, with 70% women.

In 2024, Dr. Evasovich wrote 51 Medicare Part D claims for 37 patients. 92% of them were for generic drugs. CMS names the drug for 41 of them, across 2 drugs with 11 or more claims each, at $126 in total drug cost. In 2023, CMS named 19 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Evasovich for performance year 2024, reported as part of a group. Dr. Evasovich accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 9 papers to Dr. Evasovich, published from 2013 to 2019. 2019 was the busiest year, with 3. The most frequent topics are Adenoma, Thyroid Gland and Parathyroid Neoplasms. Dr. Evasovich's most frequent co-authors are Lynn Ann Burmeister, MD, Angela Ionela Radulescu, MD and Nishant Agrawal.

CMS Open Payments shows 9 general payments to Dr. Evasovich from 4 drug and device companies from 2017 to 2025. Travel and lodging make up the largest share, 37% of the total. Novadaq Technologies Inc. paid the most, $2,227. It also lists 1 research payment totaling $750 in 2017.

Dr. Evasovich graduated from Medical College of Georgia School of Medicine in 1992.